2nd Annual

Metabolic Medicine Summit 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Sansei Fowler

Sansei Fowler

CVS Health

Close icon
Namrita Negi

Namrita Negi

Deloitte

Sansei Fowler

Sansei Fowler

CVS Health

Steve Winshel

Steve Winshel

FULLFILL

THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT

Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.

Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.

Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.

key topics for

Emerging trends in metabolic therapies and patient-centered care

Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.

Advancing biomarker-based research to enhance clinical outcomes

Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.

Case studies and clinical trials on therapies for metabolic disorders

Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.

Breakthrough in therapeutic approaches for obesity and metabolic disorders

Advanced therapies for obesity and related metabolic dysfunctions using emerging drug platforms to improve health outcomes.

Innovations in biosimilars and peptide drugs for advanced treatments

Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.

Shaping metabolic medicine with global compliance and regulatory standards

New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • PARTNERSHIPS

    25 Nov 2025

    Pharma Giants Chase the Next Liver Breakthrough
  • INSIGHTS

    24 Nov 2025

    Beyond GLP1: A New Race to Fix the Body’s Fuel System
  • REGULATORY

    20 Nov 2025

    FDA Nod for Metabolic-Liver Therapy Reshapes Treatment Horizon
  • PARTNERSHIPS

    18 Nov 2025

    New Partnership Accelerates Push for Oral Metabolic Breakthroughs

Novo Sparks a New Fight to Fix MASH

Novo Nordisk headquarters building symbolizing MASH treatment innovation

INNOVATION

14 Nov 2025

Novo’s Akero buy raises the stakes in MASH as investors await key fibrosis data

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Vanessa Navarro

Danaher Corporation

Arjun Channi

Sanofi

Gulen Tonga

Tessera Therapeutics

Show more Speakers

Past Attendees

Danaher Corporation

Sanofi

Becton Dickinson

Tessera Therapeutics

Charles River

Inovio

Seran BioScience

Körber

Chiesi USA, Inc.

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
Orlance Inc - Brand final_23starpharma_logoEnvoya_logo_algae (2)Hogne-logo@4x
arrow icon

related events in the series